Search results for "bolus"

showing 10 items of 125 documents

C1-ESTERASE INHIBITOR REVERSES FUNCTIONAL CONSEQUENCES OF SUPERIOR MESENTERIC ARTERY ISCHEMIA/REPERFUSION BY LIMITING REPERFUSION INJURY AND RESTORIN…

2006

Activated complement contributes significantly to reperfusion injury after ischemia. This study explores functional consequences of C1-esterase inhibitor (C1-INH) treatment after superior mesenteric artery occlusion (SMAO)/ reperfusion using intravital microscopy. Thirty anesthetized, spontaneously breathing, male Sprague-Dawley rats underwent SMAO for 60 min followed by reperfusion (4 h). C1-esterase inhibitor (100 and 200 IU/kg body weight) or saline (0.9%) was given as a single bolus before reperfusion. Sham-operated animals (n = 10) without SMAO served as controls.Systemichemodynamicsweremonitoredcontinuously,arterial bloodgasesanalyzedintermittently, andleukocyte/ endothelial interacti…

Malemedicine.medical_treatmentIschemiaPharmacologyCritical Care and Intensive Care MedicineRats Sprague-DawleyBolus (medicine)Mesenteric Artery Superiormedicine.arterymedicineAnimalsSuperior mesenteric arterySalinebusiness.industryMicrocirculationMetabolic acidosismedicine.diseaseRatsRegional Blood FlowMesenteric ischemiaReperfusion InjuryAnesthesiaEmergency MedicinebusinessComplement C1 Inhibitor ProteinReperfusion injuryIntravital microscopyShock
researchProduct

Preliminary analysis of mastication dynamics and fragmentation during chewing of brittle cereal foods

2013

We studied the masticatory behaviour of five commercial brittle cereal foods, with different formulations, shapes and mechanical properties, chewed by an individual. The investigation of oral behaviour consisted in a simultaneous recording of jaw kinematics and muscle activity by electromyography (EMG) and we also determined the food size distribution at the swallowing point by image analysis. Similar behaviour was found for the evolution of all criteria, and especially the predominance of compression, which could be attributed to the brittle behaviour of the foods. The amplitude of the jaw motion decreased with the number of chewing cycles, or sequence duration, whereas the maximum mastica…

Materials sciencemedicine.diagnostic_testbusiness.industry[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritiondigestive oral and skin physiologyDentistryElectromyographyMasticatory forcePreliminary analysisShear cellBrittlenessSwallowingstomatognathic systemmedicineBolus (digestion)businessMastication[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood Science
researchProduct

High dose naloxone does not improve cerebral or myocardial blood flow during cardiopulmonary resuscitation in pigs

1997

In a prospective, randomized, placebo-controlled, double-blind trial we tested the hypothesis that naloxone given during cardiopulmonary resuscitation (CPR) enhances cerebral and myocardial blood flow. Twenty-one anesthetized, normoventilated pigs were instrumented for measurements of right atrial and aortic pressures, and regional organ blood flow (radiolabeled microspheres). After 5 min of untreated fibrillatory arrest, CPR was commenced using a pneumatic chest compressor/ventilator. With onset of CPR, an i.v. bolus of 40 micrograms/kg b.w. of epinephrine was given, followed by an infusion of 0.4 micrograms/kg per min. After 5 min of CPR, either naloxone, 10 mg/kg b.w. (group N, n = 11) o…

Mean arterial pressureSwineNarcotic Antagonistsmedicine.medical_treatmentHemodynamicsEmergency NursingBolus (medicine)Coronary CirculationAnimalsMedicineCardiopulmonary resuscitationSalineAcid-Base EquilibriumDose-Response Relationship DrugNaloxonebusiness.industryHemodynamicsBlood flowCardiopulmonary ResuscitationCerebrovascular CirculationAnesthesiaEmergency MedicineArterial bloodCardiology and Cardiovascular MedicinebusinessPerfusionResuscitation
researchProduct

Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs.

2010

Naltrexone (NLX), an opioid antagonist, is widely used in the treatment of opiate addiction, alcoholism and smoking cessation. Its current peroral administration induces various adverse side effects and has limited efficacy since bioavailability and patient compliance are poor. The development of a long-acting drug delivery system of NLX may overcome the current drawbacks and help in the improvement of treatment of addiction. The primary endpoints of this study were: a) to compare the NLX bioavailability and pharmacokinetics after delivering a single transbuccal dose, released by a prototype of intraoral device, versus an intravenous (I.V.) bolus of the same drug dose; b) to verify the func…

Naltrexone HydrochlorideSwineNarcotic AntagonistsSettore MED/50 - Scienze Tecniche Mediche ApplicatePharmaceutical ScienceBiological AvailabilityPharmacologyNaltrexoneBolus (medicine)Drug Delivery SystemsPharmacokineticsSettore MED/28 - Malattie OdontostomatologicheOral administrationMedicineAnimalsNaltrexone hydrochlorideIontophoresiNLXbusiness.industryNarcotic antagonistAdministration BuccalTransmucosal deliveryBuccal administrationEquipment DesignNaltrexoneSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoIntelliDrug intraoral deviceAnesthesiaFemalePorcine buccal mucosabusinessmedicine.drugJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Gaining deeper insight into aroma perception: An integrative study of the oral processing of breads with different structures

2017

WOS:000394071900015; International audience; The objective of this study was to investigate for the first time the influence of bread structure, volatile compounds, and oral processing on aroma perception. 3 types of French baguette were created using the same raw ingredients but different bread-making processes; they consequently varied in their crumb and crust structures. We characterized the initial volatile profiles of two bread structural subtypes-namely bread crumb and bread crumb with crust-using proton transfer reaction-mass spectrometry (PTR-MS) headspace analysis. Three types of bread were characterized by thirty-nine ion fragments from m/z 45 to 139. We then conducted a study in …

Olfactory perceptionAdultMalecrumb[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[SDV]Life Sciences [q-bio]FlourcrustreleaseGas Chromatography-Mass SpectrometryBolusYoung Adult0404 agricultural biotechnologyHumansFood scienceProgressive profilingAromaFlavorTriticum2. Zero hungerprofileVolatile Organic CompoundssalivaChromatographybreakdownbiologyChemistrydigestive oral and skin physiologySensory analysesfood and beverages04 agricultural and veterinary sciencesBreadreaction-mass-spectrometrybiology.organism_classificationOlfactory Perception040401 food scienceFlavorTasteOdorantsimpactFemaleGas chromatography–mass spectrometryflavor compoundstexture[SDV.AEN]Life Sciences [q-bio]/Food and NutritionProton transfer reaction-mass spectrometry (PTR-MS)Food Science
researchProduct

Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial

2020

International audience; Background: Adjuvant treatment for stage II colon cancer remains debated. Finding a tool to select patients at risk for disease recurrence may help the clinical decision. Circulating tumor DNA (ctDNA) has been reported recently as a potential predictive marker for disease recurrence. We thus aim to test its ability to better select stage II colon cancer patients for adjuvant therapy.Methods: This national, phase III trial (NCT00002019-000935-15) conducted in more than 100 centers in France, plans to screen around 2640 patients in order to randomize (2:1; minimization method) 198 ctDNA positive patients. Patients aged 18 to 75 years with ECOG performance status ≤1 wit…

OncologyAdultMalemedicine.medical_specialtyMethylated biomarker.AdolescentColorectal cancermedicine.medical_treatment[SDV]Life Sciences [q-bio]LeucovorinRectumDisease-Free Survival03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicinemedicineAdjuvant therapyBiomarkers TumorHumansAdjuvantAgedNeoplasm StagingCirculating tumor DNAPredictive markerHepatologybusiness.industryGastroenterologyMiddle Agedmedicine.disease3. Good healthOxaliplatinColon cancerOxaliplatin[SDV] Life Sciences [q-bio]medicine.anatomical_structureTreatment OutcomeChemotherapy Adjuvant030220 oncology & carcinogenesisColonic NeoplasmsAdenocarcinoma030211 gastroenterology & hepatologyFemaleFluorouracilFranceBolus (digestion)businessAdjuvantmedicine.drug
researchProduct

Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal car…

1996

Thirty-three consecutive patients with recurrent and/or metastatic colorectal carcinoma (CRC) refractory to previous chemotherapy have been treated with levofolinic acid (I-FA) 100 mg/m2 i.v. over 1 h infusion followed by 5-fluorouracil (5-FU) 600 mg/m2 i.v. bolus every week for 6 weeks followed by a 2 week interval. Patients also received rIL-2 s.c. at 3 MU daily from day 1 to day 5 of each week for at least four consecutive weeks per cycle. Enrolled patients were divided in two groups: (i) group 1 including patients with progressive tumor refractory to chemotherapy with I-FA + 5-FU given for metastatic disease and (ii) group 2 consisting of patients with diagnosis of metastatic disease wi…

OncologyMaleCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentInjections SubcutaneousLeucovorinSalvage therapyGastroenterologyDrug Administration ScheduleBolus (medicine)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPharmacology (medical)Neoplasm MetastasisProspective cohort studyAgedPharmacologySalvage TherapyChemotherapyDose-Response Relationship Drugbusiness.industryMiddle Agedmedicine.diseaseOncologyFluorouracilToxicityInterleukin-2FemaleFluorouracilbusinessColorectal NeoplasmsProgressive diseasemedicine.drugAnti-cancer drugs
researchProduct

Identification and expression of the 11β‐steroid hydroxylase from Cochliobolus lunatus in Corynebacterium glutamicum

2019

Hydroxylation of steroids has acquired special relevance for the pharmaceutical industries. Particularly, the 11β-hydroxylation of steroids is a reaction of biotechnological importance currently carried out at industrial scale by the fungus Cochliobolus lunatus. In this work, we have identified the genes encoding the cytochrome CYP103168 and the reductase CPR64795 of C. lunatus responsible for the 11β-hydroxylase activity in this fungus, which is the key step for the preparative synthesis of cortisol in industry. A recombinant Corynebacterium glutamicum strain harbouring a plasmid expressing both genes forming a synthetic bacterial operon was able to 11β-hydroxylate several steroids as subs…

Operonlcsh:BiotechnologyGenetic VectorsGene ExpressionBioengineeringReductaseHydroxylationApplied Microbiology and BiotechnologyBiochemistryCorynebacterium glutamicumHydroxylation03 medical and health scienceschemistry.chemical_compoundPlasmidBiotransformationAscomycotalcsh:TP248.13-248.65Cloning MolecularResearch ArticlesBiotransformation030304 developmental biology0303 health sciencesbiology030306 microbiologyCochliobolus lunatusbiology.organism_classificationRecombinant ProteinsCorynebacterium glutamicumchemistryBiochemistrySteroid hydroxylaseSteroid 11-beta-HydroxylasebacteriaSteroidsBiotechnologyResearch ArticlePlasmidsMicrobial Biotechnology
researchProduct

Comparison of a 48-Hour Infusion of 5-Fluorouracil without Folinic Acid with 24-Hour Folinic Acid/5-Fluorouracil in Patients with Metastatic Colorect…

2003

<i>Background:</i> Out of various high-dose 5-fluorouracil (5-FU) regimens given with or without folinic acid (FA), the optimal 5-FU schedule has still to be defined as treatment for metastatic colorectal cancer (CRC). Consequently, we compared toxicity, response and survival following two FA/5-FU regimens in 55 CRC patients refractory to bolus FA/5-FU. <i>Methods:</i> Twenty-eight patients (group A) received 5-FU (60 mg/kg body weight) for 48 h, and 27 (group B) received 2-hour infusions of FA (500 mg/m<sup>2</sup>) and 24-hour infusions of 5-FU (2,600 mg/m<sup>2</sup>) until disease progression. <i>Results:</i> Both groups were a…

PharmacologyChemotherapymedicine.medical_specialtymedicine.drug_classbusiness.industryColorectal cancermedicine.medical_treatmentSalvage therapyGeneral Medicinemedicine.diseaseAntimetaboliteGastroenterologySurgeryFolinic acidInfectious DiseasesBolus (medicine)OncologyFluorouracilInternal medicineDrug DiscoverymedicinePharmacology (medical)Prospective cohort studybusinessmedicine.drugChemotherapy
researchProduct

Cardiovascular effects of the methanol and dichloromethanol extracts fromMentha suaveolensEhrh.

2001

Methanol and dichloromethanol extracts of the leaves and stems of Mentha suaveolens Ehrh. have been tested for their effects on resting arterial blood pressure, heart rate and noradrenaline induced hypertension. Both extracts administered by i.v. bolus to urethane anaesthetized normotensive rats reduced the mean arterial blood pressure and heart rate, while only the dichloromethanol extract prevented the noradrenaline induced hypertension.

Pharmacologymedicine.medical_specialtybusiness.industryMentha suaveolensHemodynamicsPharmacognosyPharmacologyfood.foodlaw.inventionchemistry.chemical_compoundBolus (medicine)Blood pressurefoodEndocrinologychemistrylawInternal medicineHeart rateMedicineMethanolbusinessPhytotherapyPhytotherapy Research
researchProduct